Cancer Therapy News and Research

RSS

New method for discovering potential cancer-treating compounds

A new study published in the journal Cell Reports reports a novel method by which antitumor drugs that focus on reawakening exhausted immune cells called cytotoxic T cells against cancer can be quickly identified. This could help treat a large subset of cancers that thrive because of their ability to suppress antitumor activity in T cells.

4 Dec 2019

One-third of lung cancer patients have depression symptoms, study finds

About one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depression, a new study suggests.

4 Dec 2019

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. Food and Drug Administration, according to a City of Hope-led study.

4 Dec 2019

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy, according to research presented today at EuroEcho 2019, a scientific congress of the European Society of Cardiology.

4 Dec 2019

Study identifies improved treatment option for neuroblastoma

Neuroblastoma is a rare form of malignant tumor, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now discovered, through genome sequencing, that the protein ALK and the cancer gene PIM1 are involved in the development of this tumor.

4 Dec 2019

Transplant patients diagnosed with prostate cancer may not need to delay transplantation

Immunosuppressive medications – drugs given to organ transplant recipients so their bodies won't reject the donor organ - could weaken the immune system's ability to find and destroy cancer or fight infections that contribute to cancer.

3 Dec 2019

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies.

From Sartorius 3 Dec 2019

Discovery could offer insight into different risk of diseases in African Americans

The percentage of African ancestry in a person's genome determines the level that certain genes are expressed, called mRNA, according to a new Northwestern Medicine study.

3 Dec 2019

Low-cost intervention can increase self-esteem of young cancer survivors

Young cancer survivors face unique medical and psychosocial challenges that can hinder their ability to move on mentally and socially, even years after their final treatment.

2 Dec 2019

New $300,000 grant-funded program to address opioid prescribing for cancer patients

The University of Illinois at Chicago has received a grant from the Coleman Foundation to develop a screening process for prescribing opioids and managing opioid use disorders in cancer patients who receive care at UI Health, UIC's clinical health enterprise.

2 Dec 2019

Painful endometriosis symptoms could be reduced with a cancer drug

The painful symptoms of endometriosis - a chronic condition which affects millions of women - could potentially be reduced with a drug that had previously been investigated as a cancer treatment.

2 Dec 2019

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown.

27 Nov 2019

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences identified a key mechanism for how antiviral immune responses reprogram liver metabolism. Their recent study, which was published in the renowned scientific journal Immunity, investigated the communication between inflammation and liver metabolism during chronic viral infection.

26 Nov 2019

Cancer patients more likely to die from heart disease, stroke, study found

Heart disease and stroke are the leading causes of death worldwide. Now, a team of researchers found that cancer-stricken patients are at a higher risk of dying from cardiovascular diseases (CVD). More than one in ten cancer patients don’t die from cancer itself, rather from heart and blood vessel conditions.

25 Nov 2019

New targeted treatment to fight against deadly pancreatic cancer

Every day, more than 1200 people worldwide are told they have pancreatic cancer. Within 12 months, 80 per cent of them will have succumbed to the disease.

25 Nov 2019

Cancer patients have higher risk of cardiovascular death

A new study says that over 10% of patients with cancer die of unrelated cardiovascular disease (CVD) rather than their cancers.

25 Nov 2019

Risk of death from heart disease found to be higher in cancer patients

More than one in ten cancer patients do not die from their cancer but from heart and blood vessel problems instead, according to new research published in the European Heart Journal today. For some cancers, like breast, prostate, endometrial, and thyroid cancer, around half will die from cardiovascular disease (CVD).

25 Nov 2019

UVA doctors decry aggressive billing practices by their own hospital

Prominent doctors at UVA Health System are expressing public outrage at their employer’s practices to collect unpaid medical debt from its patients.

23 Nov 2019

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

On Nov. 21, 2019, the U.S. Food and Drug Administration approved the use of the drug acalabrutinib for first-line therapy in chronic lymphocytic leukemia and small cell lymphoma.

22 Nov 2019

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic breast cancer, according to a large, randomized phase III study reported at the ESMO Asia 2019 Congress.

22 Nov 2019

Cancer Therapy News and Research

New method for discovering potential cancer-treating compounds

One-third of lung cancer patients have depression symptoms, study finds

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Study identifies improved treatment option for neuroblastoma

Transplant patients diagnosed with prostate cancer may not need to delay transplantation

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Discovery could offer insight into different risk of diseases in African Americans

Low-cost intervention can increase self-esteem of young cancer survivors

New $300,000 grant-funded program to address opioid prescribing for cancer patients

Painful endometriosis symptoms could be reduced with a cancer drug

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Key mechanism identified for how antiviral immune responses reprogram liver metabolism

Cancer patients more likely to die from heart disease, stroke, study found

New targeted treatment to fight against deadly pancreatic cancer

Cancer patients have higher risk of cardiovascular death

Risk of death from heart disease found to be higher in cancer patients

UVA doctors decry aggressive billing practices by their own hospital

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Your guide to microplate readers for cancer research eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News